| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da6012a6809db78e155927b5ba9b955d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-315
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3231
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-341
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3341
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-346
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3515
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3525
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3517 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7125 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 |
| filingDate |
2016-09-26^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1bab9742e845e56eafb7c4f3f7a160c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_539fd45554fb14da04e6d78fc59479af
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74c3f62705ec8baff74a32c28dfacf3a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc72972a7caa694436fe14be93493dfe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aed1ca9f4889f396f4310cfffa1d1d73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e9b7b79755788d63514b1d00d37a207 |
| publicationDate |
2017-03-30^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2017053995-A1 |
| titleOfInvention |
Conjugated antisense compounds and their use |
| abstract |
Provided herein are oligomeric compounds comprising a modified oligonucleotide and a conjugate group for modulating the amount or activity of a target nucleic acid in extra hepatic tissues and extra hepatic cells. Also provided herein are methods of modulating the amount or activity of an extra-hepatic nucleic acid target in a cell comprising contacting the cell with the oligomeric compound or antisense compound. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11299737-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11359197-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11198867-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11058767-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019182037-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021153747-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021177418-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019118916-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11447775-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020061497-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11116843-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11725208-B2 |
| priorityDate |
2015-09-25^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |